Latest Race Oncology News

+

Race Oncology appoints Associate Professor Erin Howden to scientific advisory board Howden has researched adverse effects of chemotherapy on cardiovascular…

Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the company’s movements…

Leading cardiologist says bisantrene has potential to significantly change cancer treatment landscape Bisantrene could minimise damage to the heart linked…